Overview
The symptomatic form of Coffin-Lowry syndrome in female carriers refers to the clinical manifestations that can occur in heterozygous females who carry a pathogenic variant in the RPS6KA3 gene on the X chromosome. While Coffin-Lowry syndrome (CLS) classically presents as a severe condition in affected males, female carriers can exhibit a wide spectrum of symptoms due to variable X-chromosome inactivation (lyonization). This condition is also referred to as manifesting carrier status for Coffin-Lowry syndrome. Female carriers may display milder but clinically significant features affecting multiple body systems. Key manifestations can include mild to moderate intellectual disability or learning difficulties, characteristic facial features (such as a prominent brow, wide nose with thick nasal septum, and full lips), short stature, and skeletal abnormalities including tapering or puffy fingers. Some carrier females may experience stimulus-induced drop attacks (sudden episodes of collapse triggered by unexpected stimuli such as touch or sound), which are a well-recognized feature of CLS. Cardiac involvement, including mitral valve prolapse, has also been reported in some carriers. The severity of symptoms varies considerably among affected females, ranging from very mild features that may go unrecognized to presentations approaching the severity seen in affected males. There is currently no cure or disease-specific treatment for the symptomatic form of Coffin-Lowry syndrome in female carriers. Management is supportive and symptom-based, including educational support for learning difficulties, physical and occupational therapy, orthopedic management for skeletal issues, and neurological monitoring for drop attacks. Anticonvulsant medications such as clonazepam or valproate may be considered for stimulus-induced drop episodes. Genetic counseling is important for carrier females regarding recurrence risks in future pregnancies.
Clinical phenotype terms— hover any for plain English:
X-linked dominant
Carried on the X chromosome; a single copy can cause the condition
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Symptomatic form of Coffin-Lowry syndrome in female carriers.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Symptomatic form of Coffin-Lowry syndrome in female carriers at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Symptomatic form of Coffin-Lowry syndrome in female carriers.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Symptomatic form of Coffin-Lowry syndrome in female carriers.
Community
No community posts yet. Be the first to share your experience with Symptomatic form of Coffin-Lowry syndrome in female carriers.
Start the conversation →Latest news about Symptomatic form of Coffin-Lowry syndrome in female carriers
No recent news articles for Symptomatic form of Coffin-Lowry syndrome in female carriers.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Symptomatic form of Coffin-Lowry syndrome in female carriers
What is Symptomatic form of Coffin-Lowry syndrome in female carriers?
The symptomatic form of Coffin-Lowry syndrome in female carriers refers to the clinical manifestations that can occur in heterozygous females who carry a pathogenic variant in the RPS6KA3 gene on the X chromosome. While Coffin-Lowry syndrome (CLS) classically presents as a severe condition in affected males, female carriers can exhibit a wide spectrum of symptoms due to variable X-chromosome inactivation (lyonization). This condition is also referred to as manifesting carrier status for Coffin-Lowry syndrome. Female carriers may display milder but clinically significant features affecting mul
How is Symptomatic form of Coffin-Lowry syndrome in female carriers inherited?
Symptomatic form of Coffin-Lowry syndrome in female carriers follows a x-linked dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.